Human bone morphogenetic protein-2 composite material and its preparation method and application
A technology of morphogenic proteins and composite materials, applied in the field of biomedicine, can solve problems such as high cost, clinical complications, and high doses
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0138] The preparation of embodiment 1 porous bone-like apatite
[0139] 1 g of composite calcium phosphate salt powder composed of tetracalcium phosphate (TTCP) and anhydrous dicalcium phosphate (Dicalcium Phosphate Anhydrate, DCPA) in equimolar ratio, 1 g of NaCl particles (particle size about 500 μm), saturated NaCl solution 0.3g was mixed to obtain a uniform slurry, and the slurry was filled into a cylindrical mold with a diameter of 4mm and a height of 3mm and maintained at a pressure of 2MPa for 1min to obtain a scaffold body of a corresponding size and shape.
[0140] The stent embryo was cured in a constant temperature and humidity box at 37° C. and 100% humidity for 3 days, soaked in distilled water to completely dissolve NaCl, and then dried at 100° C. for 12 hours to obtain a porous bone-like apatite carrier.
[0141] Such as figure 1 As shown, the porous bone-like apatite carrier is a cylinder with a diameter of about 4 mm and a height of about 3 mm ( figure 1 A)...
Embodiment 2
[0143] Example 2 - Composite 1: 1 μg rhBMP-2 with 6 μg dexamethasone
[0144] Take 1 g of the porous bone-like apatite carrier described in Example 1 and carry out high-temperature and high-pressure steam sterilization. Under sterile conditions, add a solution containing 1 μg of rhBMP-2 and 6 μg of dexamethasone dropwise on the porous bone-like apatite placed on the carrier in a vacuum desiccator, vacuumed with a vacuum pump and maintained for 30 minutes, so that the solution is fully absorbed into the pores of the support.
[0145] Then the scaffold was taken out from the vacuum desiccator, and aseptically freeze-dried with a vacuum freeze dryer to obtain composite material 1. The immobilized amount of rhBMP-2 in composite material 1 was 1 μg, and it could be sealed at 4°C for long-term storage.
Embodiment 3
[0146] Example 3 - Composite 2: 1 μg rhBMP-2 with 3 μg dexamethasone
[0147] Same as Example 2, except that the amount of dexamethasone is 3 μg, and the immobilized amount of rhBMP-2 in composite material 2 is 1 μg.
PUM
| Property | Measurement | Unit |
|---|---|---|
| pore size | aaaaa | aaaaa |
| particle diameter | aaaaa | aaaaa |
| diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


